Background and study aim: The total number of upper gastrointestinal endoscopies is increasing, and despite
guidelines for endoscopy referral for general practitioners, the proportion of patients
found to have no endoscopic abnormalities is still up to 60 % (and increasing). The
aim of this study was to assess the association between general practitioners’ referral
indications and endoscopic findings.
Patients and methods: General practitioners of patients referred for an open-access endoscopy between January
2002 and December 2004 were asked to specify the reason for referral on a specially
designed form. The relative frequency of patients actually having an endoscopic abnormality
was assessed for each referral indication.
Results: A total of 1298 people were included in the study. A relevant endoscopic abnormality
was found in 48 % of patients. Patients with an endoscopic abnormality were not more
often referred with “alarm” symptoms or failure of empirical treatment than patients
without an abnormal endoscopic finding (31 % with an endoscopic abnormality vs. 30
% without an endoscopic abnormality had alarm symptoms; 57 % of people in both groups
experienced failure of empirical treatment). Referral with alarm symptoms had a positive
predictive value of 4 % for cancer (prevalence 2 %; P < 0.01), and referral with reflux-like symptoms had a positive predictive value of
33 % for finding reflux esophagitis (prevalence 22 %; P < 0.01).
Conclusions: General practitioners’ referral indications for open-access endoscopy did not add
any relevant predictive value for endoscopic findings in comparison with what might
have been expected from overall prevalence. Only alarm symptoms slightly increased
the probability of finding cancer and only reflux-like symptoms slightly increased
the probability of finding reflux esophagitis.
References
1
Talley N J, Silverstein M D, Agreus L. et al .
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.
Gastroenterology.
1998;
114
582-595
2
Talley N J, Zinsmeister A R, Schleck C D. et al .
Dyspepsia and dyspepsia subgroups: a population-based study.
Gastroenterology.
1992;
102
1259-1268
3
Talley N J, Vakil N.
Guidelines for the management of dyspepsia.
Am J Gastroenterol.
2005;
100
2324-2337
4 Quality Institute for Healthcare CBO and Dutch Federation of General Physicians
NHG .Multidisciplinaire Richtlijn Maagklachten. 2004 http://www.cbo.nl
5
Stanghellini V, Tosetti C, Barbara G. et al .
Review article: the continuing dilemma of dyspepsia.
Aliment Pharmacol Ther.
2000;
14 Suppl 3
23-30
6
Talley N J, Vakil N, Delaney B. et al .
Management issues in dyspepsia: current consensus and controversies.
Scand J Gastroenterol.
2004;
39
913-918
7
van Kerkhoven L AS, van Ryswyck S J, van Rossum L GM. et al .
Evaluation of endoscopy outcomes a decade after the nationwide introduction of protonpump
inhibitors and guidelines for Helicobacter pylori eradication.
Gastroenterology.
2006;
130 (4)
A459
8 National Institute for Clinical Excellence .Dyspepsia: managing dyspepsia in adults
in primary care. 2004 http://http://www.nice.org.uk/pdf/CG017NICEguideline.pdf
9
Kapoor N, Bassi A, Sturgess R. et al .
Predictive value of alarm features in a rapid access upper gastrointestinal cancer
service.
Gut.
2005;
54
40-45
10
Wallace M B, Durkalski V L, Vaughan J. et al .
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia:
a multicentre database study.
Gut.
2001;
49
29-34
11
Numans M E, van der Graat G Y, de Wit N J. et al .
How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation
of diagnostic determinants for gastro-oesophageal malignancy.
Scand J Gastroenterol.
2001;
36
437-443
12
Moayyedi P, Talley N J, Fennerty M B. et al .
Can the clinical history distinguish between organic and functional dyspepsia?.
JAMA.
2006;
295
1566-1576
13
Smith T, Verzola E, Mertz H.
Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Gastrointest Endosc.
2003;
58
9-13
14
Fransen G A, Janssen M J, Muris J W. et al .
Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy.
Aliment Pharmacol Ther.
2004;
20
1045-1052
15
Voutilainen M, Mantynen T, Mauranen K. et al .
Is it possible to reduce endoscopy workload using age, alarm symptoms and H. pylori
as predictors of peptic ulcer and oesophagogastric cancers?.
Dig Liver Dis.
2005;
37
526-532
16
Manes G, Balzano A, Marone P. et al .
Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access
endoscopy system: a prospective observational study based on the Maastricht guidelines.
Aliment Pharmacol Ther.
2002;
16
105-110
17
Johnsen R, Bernersen B, Straume B. et al .
Prevalences of endoscopic and histological findings in subjects with and without dyspepsia.
BMJ.
1991;
302
749-752
18
Lehmann F S, Renner E L, Meyer-Wyss B. et al .
Helicobacter pylori and gastric erosions: results of a prevalence study in asymptomatic
volunteers.
Digestion.
2000;
62
82-86
19
Ecclissato C, Carvalho A F, Ferraz J G. et al .
Prevalence of peptic lesions in asymptomatic, healthy volunteers.
Dig Liver Dis.
2001;
33
403-406
20
Lassen A, Hallas J, De Muckadell O B.
First-time endoscopy and use of antisecretory medication: a population-based cohort
study.
Scand J Gastroenterol.
2005;
40
705-712
21
Blustein P K, Beck P L, Meddings J B. et al .
The utility of endoscopy in the management of patients with gastroesophageal reflux
symptoms.
Am J Gastroenterol.
1998;
93
2508-2512
22
Wiklund I, Glise H, Jerndal P. et al .
Does endoscopy have a positive impact on quality of life in dyspepsia?.
Gastrointest Endosc.
1998;
47
449-454
23
Bytzer P, Hansen J M, Schaffalitzky de Muckadell O B.
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.
Lancet.
1994;
343
811-816
24
van Kerkhoven L A, van Rossum L G, van Oijen M G. et al .
Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia.
Endoscopy.
2006;
38
879-885
L. van Kerkhoven, MSc
Department of Gastroenterology
Radboud University Nijmegen Medical Center
P.O. Box 9101
6500 HB Nijmegen
The Netherlands
Fax: +31-243540103
Email: L.vanKerkhoven@MDL.umcn.nl